Aggressive Treatment in Pediatric Patients With Drug-Induced Hypersensitivity Syndrome/Drug Reaction With Eosinophilia and Systemic Symptoms Is Associated With Future Development of Type III Polyglandular Autoimmune Syndrome
October 2018
in “
BMJ Case Reports
”
TLDR Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.
The study discussed a 6-year-old boy with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) who developed type III polyglandular autoimmune syndrome (PASIII) following aggressive treatment with intravenous immunoglobulin (IVIG) and prednisolone. A literature review identified five similar cases, suggesting that while these treatments were effective short-term, they might increase the risk of long-term autoimmune issues in pediatric patients. The study recommended careful screening for autoantibodies and advised against therapies that could hasten immune recovery, potentially leading to PASIII.